Table 2 Comparison of Nuclear & Cytoplasmic expression of TCF-4 protein in tumor samples
From: TCF 4 tumor suppressor: a molecular target in the prognosis of sporadic colorectal cancer in humans
| Â | TCF-4 (Cytoplasmic) IHC | Total | |||
|---|---|---|---|---|---|
NO | YES | ||||
TCF-4 (Nuclear) IHC | NO | Count | 0 | 11 | 11 |
% within TCF-4 (Nuclear) IHC | 0.0% | 18.3% | 18.3% | ||
YES | Count | 10 | 39 | 49 | |
% within TCF-4 (Nuclear) IHC | 16.6% | 65% | 100.0% | ||
Total | Count | 10 | 50 | 60 | |
% within TCF-4 (Nuclear) IHC | 16.6% | 83.3% | 100.0% | ||